REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 36 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $16,000 | -15.8% | 23,500 | 0.0% | 0.00% | – |
| Q3 2014 | $19,000 | -79.8% | 23,500 | -78.1% | 0.00% | -100.0% |
| Q2 2014 | $94,000 | -5.1% | 107,500 | +16.8% | 0.00% | 0.0% |
| Q1 2014 | $99,000 | +482.4% | 92,000 | +176.0% | 0.00% | – |
| Q4 2013 | $17,000 | +13.3% | 33,339 | 0.0% | 0.00% | – |
| Q3 2013 | $15,000 | -37.5% | 33,339 | -37.5% | 0.00% | – |
| Q2 2013 | $24,000 | – | 53,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northeast Financial Consultants Inc | 150,000 | $109,000 | 0.05% |
| CONDOR CAPITAL MANAGEMENT | 211,371 | $154,000 | 0.04% |
| Benin Management CORP | 83,000 | $61,000 | 0.03% |
| First Heartland Consultants, Inc. | 20,000 | $15,000 | 0.01% |
| Advisory Services Network, LLC | 22,000 | $16,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $131,000 | 0.00% |
| Moors & Cabot, Inc. | 11,000 | $7,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 3,000 | $2,000 | 0.00% |
| Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
| WFG Advisors, LP | 3,500 | $3,000 | 0.00% |